ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXAMINES INCLUSION OF FUTURE MEDICAL COSTS IN HEALTH TECHNOLOGY ASSESSMENT GUIDELINES

Published Nov 2, 2016
Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel entitled, Should Health Technology Assessment Guidelines Recommend Inclusion of Future Medical Costs?, at the Society’s 19th Annual European Congress in Vienna, Austria.  The issue panel was moderated by Andrew Briggs, DPhil, MSc, William R, Lindsay Chair of Health Economics and Professor of Health Economics, University of Glasgow, Glasgow, UK. Panelists for the issue panel included:
  • Alec Morton, PhD, Professor, Management Science, University of Strathclyde, Glasgow, UK
  • Pieter van Baal, PhD, Associate Professor, Institute for Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands
  • Ad Antonisse, MSc, Director Economic Affairs (Market Access and Public Affairs), AstraZeneca, Zoetermeer, The Netherlands
This session explored whether health technology assessment (HTA) guidelines should recommend the inclusion of “unrelated future costs” of a medical technology. Recently, Dutch HTA guidelines were changed to recommend inclusion of future, unrelated medical costs. Currently, however, many HTA guidelines exclude future medical costs from an appraisal. For example, the costs of caring for a patient with dementia after preventing death from stroke would not be included in a cost effectiveness analysis of a thrombolysis treatment. The panelists presented the benefits and disadvantages of including future, unrelated costs in HTA guidelines. Alec Morton, PhD provided a summary of theoretical arguments for and against inclusion of future unrelated medical costs. Pieter van Baal, PhD reviewed approaches for how these future costs can be estimated in practice. Ad Antonisse, MSc provided the industry perspective on the issue. Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.

###

Related Stories

Progress and Paradox: Healthcare Reform, Innovation, and Inequality in the Arabian Gulf and Wider Region

Apr 1, 2026

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that presents a comprehensive body of evidence aimed at advancing value-based healthcare across the Arabian Gulf and the wider Middle East and North Africa region. Guest editors for the themed section are Paul Revill, Sara Al-Dallal, and Anderson Stanciole. The series was published in the March 2026 issue of Value in Health Regional Issues.

ISPOR Launches Overview of the US Healthcare System

Mar 31, 2026

ISPOR has launched a new resource that provides an overview of the healthcare system in the United States. The United States has a population of more than 300 million people and is supported by one of the most complex healthcare systems in the world. ISPOR's new website—US Healthcare System Overview—provides a summary of this intricate and highly unique healthcare system.

ISPOR’s “HEOR Explained” and “HEOR News Desk” Win Major Industry Awards

Feb 24, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that its HEOR Explained website and videos along with its HEOR News Desk were recognized with a number of prominent industry awards from the dotCOMM, MarCom, and Viddy Awards.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×